Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register
      S&P 500
      4,274.51
      (
      0.02%
      )
      US Tech 100
      14,230.76
      (
      0.44%
      )
      Dow Jones
      33,550.27
      (
      -0.2%
      )
      Brent Oil
      94.305
      (
      1.85%
      )
      Bitcoin
      26,249.62
      (
      0.16%
      )
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. InflaRx NV (IFRX)

      7. InflaRx NV (IFRX) News

      IFRX InflaRx NV

      2.66
      -0.24 (-8.28%)
      After Hours
      Last Updated: 16:30:00
      Delayed by 15 minutes

      Register Free for Streaming Quotes & Tools

      Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

      Register
      Company Name Stock Ticker Symbol Market Type
      InflaRx NV IFRX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.24 -8.28% 2.66 16:30:00
      Open Price Low Price High Price Close Price Prev Close
      2.90 2.58 2.96 2.66 2.90
      more quote information »

      Recent News

      Date Time Source Heading
      9/27/20239:49IHNWFeaturedSciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
      9/26/20238:37IHNWFeatured1606 Corp. Partners with Cool Blue To Launch ChatCBD, a New AI Customer Experience
      9/11/202308:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/11/202307:00GLOBEInflaRx Announces Positive Topline Results from the Single..
      8/30/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/30/202307:30GLOBEInflaRx’s Marketing Authorization Application (MAA) for..
      8/10/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/10/202307:30GLOBEInflaRx Reports Second Quarter 2023 Financial Results &..
      7/12/202316:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      7/12/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      6/30/202316:06EDGAR2Form F-3 - Registration statement by foreign private issuers
      6/28/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      6/28/202307:30GLOBEInflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
      6/21/202307:00GLOBEInflaRx Announces Commercial Launch of Gohibic (vilobelimab)..
      5/11/202307:30GLOBEInflaRx Reports First Quarter 2023 Financial and Operating..
      4/18/202316:01GLOBEInflaRx Announces Closing of the Full Exercise of Greenshoe..
      4/14/202316:01GLOBEInflaRx Announces Closing of $40 Million Public Offering of..
      4/11/202321:08GLOBEInflaRx Announces Pricing of $40 Million Public Offering of..
      4/11/202316:00GLOBEInflaRx Announces Public Offering of Ordinary Shares
      4/05/202311:30DJNInflaRx Shares Soar 40% on FDA Emergency Use Authorization..
      4/04/202315:42DJNInflaRx's Gohibic Gets Emergency Use Authorization from FDA..
      4/04/202314:55GLOBEInflaRx Receives FDA Emergency Use Authorization for Gohibic..
      3/22/202307:30GLOBEInflaRx Reports Full Year 2022 Financial and Operating..
      1/05/202307:30GLOBEInflaRx Provides Update on Planned Phase III Study Design in..
      12/21/202207:30GLOBEInflaRx Announces Amendment of Co-Development Agreement and..
      11/20/202223:15TRMNSVB Securities Sticks to Their Buy Rating for InflaRx (IFRX)
      11/13/202222:55TRMNInflaRx (IFRX) Gets a Buy from SVB Securities
      11/10/202211:36TRMNRaymond James Reaffirms Their Buy Rating on InflaRx (IFRX)
      11/10/202206:16TRMNH.C. Wainwright Keeps Their Buy Rating on InflaRx (IFRX)
      11/09/202207:40GLOBEInflaRx Initiates First-in-Human Study with Small Molecule..
      11/09/202207:30GLOBEInflaRx Reports Third Quarter 2022 Financial & Operating..
      9/29/202207:30GLOBEInflaRx Submits Request for Emergency Use Authorization to..